Recap: Kiora Pharmaceuticals Q1 Earnings

Kiora Pharmaceuticals (NASDAQ:KPRX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:00 AM. Here's what investors need to know about the announcement.

byBenzinga Insights

May 9, 2023

1 minute read

Kiora Pharmaceuticals (NASDAQ:KPRX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Kiora Pharmaceuticals beat estimated earnings by 40.48%, reporting an EPS of $-1.0 versus an estimate of $-1.68.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.52 which was followed by a 3.4% increase in the share price the next day.

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Kiora Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

$1000 Invested In Valero Energy 10 Years Ago Would Be Worth This Much Today

By Benzinga Insights

October 5, 10:16 AM

Valero Energy (NYSE:VLO) has outperformed the market over the past 10 years by 5.01% on an annualized basis producing an average annual return of 15.0%. Currently, Valero Energy has a market capitalization of $45.70 billion.

VLO

DraftKings: Q2 Earnings Insights

By Benzinga Insights

August 5, 7:23 AM

DraftKings (NASDAQ:DKNG) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings DraftKings reported an EPS of $-0.29.

DKNG

Tilray’s Diversified Growth Strategy Is Paying Off, Here’s What’s Behind 34% YoY Revenue Increase In Q2

By Jelena Martinovic

January 9, 9:54 AM

Canadian cannabis company Tilray reported a 34% increase in revenue in its second quarter of fiscal 2024. The company reported revenue of $194 million, up from $145 million in the same period last year. Tilray's cannabis net revenue increased 35% to $67 million, while beverage alcohol net revenue increased 117% to $47 million. Distribution net revenue also rose to $67 million, compared to $60 million in the same quarter last year. The company's gross profit increased 11% to $47 million, with adjusted gross profit up 18% to $52 million. Net loss in the second quarter amounted to $46 million, compared to a net loss of $62 million in the same period last year. Adjusted EBITDA stood at $10.1 million, down from $11 million in Q2 2023.

TLRY